Literature DB >> 2875304

Exacerbation of asthma after nebulised beclomethasone diproprionate.

R J Clark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875304     DOI: 10.1016/s0140-6736(86)90140-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

Review 3.  Sensitisation to corticosteroids. Consequences for anti-inflammatory therapy.

Authors:  A Dooms-Goossens
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 4.  Adverse drug events related to dosage forms and delivery systems.

Authors:  I F Uchegbu; A T Florence
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 5.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

6.  The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.

Authors:  K A Miszkiel; R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

7.  Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.

Authors:  P Rafferty; R Beasley; S T Holgate
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.